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Background: The mechanisms through which the avian influenza virus H5N1 modulate the host’s innate immune
defense during invasion, remains incompletely understood. RIG-I as a pattern recognition receptor plays an
important role in mediating innate immune response induced by influenza virus. So, modulating RIG-I might be
adopted as a strategy by influenza virus to antagonize the host’s innate immune defense.
Methods: Here we chose an avian influenza virus A/tree sparrow/Henan/1/04 (H5N1) directly isolated from a free-
living tree sparrow in Mainland China which is amplified in egg allantoic cavity, and researched its interferon
induction and manipulation of RIG-I expression compared with influenza virus A/WSN/1933(H1N1), a well
characterized mouse adapted strain, in human lung epithelial A549 cells and human embryonic kidney 293T cells.
Results: Although the avian influenza virus H5N1 infection initiated a rapid IFN-beta production early on, it
eventually presented a more potent inhibition to IFN-beta production than H1N1. Correspondingly, the H5N1
infection induced low level expression of endogenous RIG-I, an Interferon Stimulating Gene (ISG), and showed
more potent inhibition to the expression of endogenous RIG-I triggered by exogenous interferon than H1N1.
Conclusions: Manipulating endogenous RIG-I expression might constitute one of the mechanisms through which
avian influenza virus H5N1 control the host’s innate immune response during infection.
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Avian H5N1 influenza viruses were first recognized to
be capable of causing human respiratory infection and
disease in Hong Kong in 1997 when 18 documented
human H5N1 infections with 6 fatalities were identified
in conjunction with outbreaks of H5N1 disease among
domestic poultry [1-3]. As a result of avian-to-human
transmission, 373 laboratory-confirmed human cases
(236 deaths) of H5N1 virus infection in 14 countries
have been reported to the World Health Organization
from 2003 to 18 March 2008 [4], highlighting the pan-
demic potential of H5N1 viruses and their growing* Correspondence: tong62035@gmail.com
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reproduction in any medium, provided the orinfluence on global public health. Since the 1997 H5N1
avian influenza virus transmission from chicken to
human in Hong Kong, cross-species transmissibility of
avian influenza virus H5N1 is a major concern in influ-
enza research, but the underlying mechanism(s) of
cross-species transmission and the heightened virulence
of H5N1 viruses to humans remain largely unknown.
Since first identified in choriontic membranes of
embryonated chicken eggs, interferon has been regarded
as an important defence line in controlling virus infec-
tion [5-7]. In order to successfully invade and amplify,
influenza virus has evolved to obtain so many strategies
to fight against the above defence system during inter-
playing with hosts [8]. Retinoic acid-inducible gene-I
(RIG-I) as an Pattern Recognition Receptor(PRR) sens-
ing viral cytoplasmic RNA ligand located on the extremeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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production [9]. So RIG-I would be controlled or modi-
fied to downregulate interferon activation by some
viruses such as influenza virus and Hepatitis C Virus
[10], but the mechanisms have not been understood
completely.
Considering the important role of innate immune re-
sponse in controlling virus transmission and pathogen-
esis [11,12], in the current study, a novel genotype
H5N1 strain A/tree sparrow/Henan/1/04(H5N1) isolated
from a tree sparrow in Mainland China was chosen [13]
and its interferon-beta (IFN-β) induction and modula-
tion of endogenous RIG-I expression were compared
with human influenza virus H1N1 in human lung epi-
thelial cells. Although the avian influenza virus H5N1 in-
fection caused rapid IFN-β production in early infection,
in the late stage of infection, the H5N1 strain showed
more potent IFN-β inhibition and induced low level en-
dogenous RIG-I expression than human influenza virus
H1N1. Our results further approved that through ma-
nipulating innate immune response even the expression
of RIG-I, avian influenza virus H5N1 struggle to control
the host’s innate immune defense system for facilitating
its invasion.
Results
Avian influenza virus A/tree sparrow/Henan/1/04 (H5N1)
induces more rapid IFN-β production than human
influenza virus H1N1 in early infection
Innate immune response constitutes the first line of
defense when a host encounters viral infections, but in
the case of influenza virus infection, only low level or
moderate IFN production is induced, and a different in-
duction ability is apparent [14]. Our results also demon-
strated this different inducing pattern. When normalized
with multiplicity of infection, based on the level of nu-
cleotide protein (NP) gene mRNA, we observed that the
avian influenza virus A/tree sparrow/Henan/1/04(H5N1)
infection was followed with more rapid and potent NP
gene expression compared with human influenza virus
H1N1 in the same multiplicity of infection (Figure 1A).
In accordance with its robust gene expression in early
infection (0–8 h), the avian influenza virus H5N1
induced rapid and potent IFN-β production at 4h post
infection compared with H1N1, but this pattern abruptly
went down in late infection (12–24 h) (Figure 1B).
Avian influenza virus H5N1 infection induced low level
endogenous RIG-I expression
RIG-I not only functions as a PRR to initiate interferon
production but also inducible by endogenous or exogen-
ous interferon as an Interferon Stimulated Gene (ISG)
[15,16]. Previous studies have demonstrated that al-
though single strand RNA (ssRNA) from influenza viruscan be recognized by RIG-I [17] and activate down-
stream signaling molecules, influenza virus infection
only induces weak IFN production because NS1 protein
blocks the IFN signaling pathway [18]. Here we observed
that although A/tree sparrow/Henan/1/04(H5N1) effect-
ively infected human lung epithelial cells and induced
rapid IFN-β production during early infection (0-4h)
(Figure 1B), its infection only induces low level endogen-
ous RIG-I expression compared with H1N1 in A549
cells based on western blot and RT-PCR and that they
are in agreement (Figure 2).
RIG-I is involved in recognizing H5N1 to produce
interferon-beta
Innate immune pattern recognition receptors exist at
the extreme upstream of IFN signaling pathway, and dif-
ferent PRRs recognize the specific components from in-
vading microbial pathogens and initiate innate immune
response [19-22]. RIG-I has been identified as the cyto-
solic innate immune PRR that mediates IFN production
through recognizing 5-termial ppp single strand RNA
[23]. Previous studies indicated that RIG-I was respon-
sible for mediating IFN production when sensing influ-
enza virus in epithelial cells [24]. Pretreating the A549
cells with IFN-α or TNF-α increases RIG-I expression
and enhances the IFN production induced by influenza
virus infection [15,16]. Our results also proved that as
with other influenza virus strains, RIG-I was involved in
the recognition of A/tree sparrow/Henan/1/04(H5N1)
infection. Over expressing RIG-I K270A (a dominant
negative construct of RIG-I) significantly inhibits the
IFN-β reporter response induced by A/tree sparrow/
Henan/1/04(H5N1) or H1N1 infection (Figure 3A).
Meanwhile, over expressing wild type RIG-I in 293T
cells significantly increased STAT-1 phosphorylation in a
time dependent manner with increasing phosphorylation
seen for 8 hours versus 4 hours, which signals in IFN
production (Figure 3B).
The infection of H5N1 exerted potent blockage to
endogenous RIG-I expression when treated with
exogenous interferon
In order to further assess the ability of antagonizing
interferon and manipulation to endogenous RIG-I ex-
pression, 293T cells were pre-infected with H5N1 and
H1N1, and then treated with human IFN-α2b. The
results indicated that although both of the influenza
viruses showed somewhat inhibition to exogenous inter-
feron and decreaed endogenous RIG-I expression, H5N1
gave more potent inhibition to endogenous RIG-I ex-
pression induced by exogenous interferon than H1N1
(Figure 4A). NS1 has been recognized as the key compo-
nent acting as antagonizing interferon. In this assay, we
also found that as shown in the case of infection, NS1
Figure 1 Infection of avian influenza virus H5N1 resulted in robust NP gene expression and rapid IFN-β production. A549 cells were
infected with influenza viruses(m.o.i = 2). At the indicated time point, cells were collected and performed to extract total RNA. Quantitative RT-PCR
was used to detect the copy numbers of the influenza virus NP gene, human IFN-β gene in A549 cells, and normalized with human β-actin gene
copy numbers. Data are shown as mean± SD of three independent experiments. (A) The expression pattern of NP gene in A549 cells. (B) The
induction of IFN-β gene in A549 cells. Significance was determined using two-tailed Student’s t test (*, P < 0.05).
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sponse of IFN-stimulated response element (ISRE) re-
porter gene induced by exogenous interferon than H1N1
(Figure 4B).Figure 2 H5N1 infection induced low level endogenous RIG-I
expression. The A549 cells were infected with H5N1 or H1N1 (m.o.
i = 2) for 1 h, then the supernatant was replaced with fresh medium
and culturing was continued. At the indicated time, the cells were
collected. Half of the cells were used to detect endogenous RIG-I
expression, and human β-actin was used as the loading control. The
other half of the cells was used to extract total RNA and synthesize
cDNA as previously demonstrated. Semiquantitative PCR was used
to detect the RIG-I and human β-actin mRNA level.Discussion
The critical role of the IFN system in controlling influenza
virus transmission was first demonstrated in a classical ex-
periment wherein mice infected with influenza virus and
injected with anti-IFN serum were observed to produce
higher titers of the virus and an exacerbated pathology
[25]. Subsequent studies in knockout mice with defects in
their IFN system have confirmed this basic observation
[26]. Recent studies in which the IFN-inducing capacity
varied in genetically related A-type influenza virus showed
that the strain capable of producing the most IFN was
attenuated in its pathogenesis in mice [27,28]. The above
researches indicate that IFN plays an important role in
limiting human influenza virus or avian influenza virus
pathogenesis or transmission.
Since the first reported human case of avian influenza
virus H5N1 infection in Hong Kong in 1997 [2], the
avian to human or human to human transmission of
H5N1 poses a potential threat to human health. Aquatic
birds are considered the natural host of avian influenza
virus H5N1 [29]. But recently, some terrestrial birds,
such as tree sparrows, have been found carrying H5N1
with no symptoms [30]. This indicates that the host
range of avian influenza virus maybe expanding. In
addition, some new H5N1 genotypes are emerging
through gene reassortment [13,31]. How those avian in-
fluenza viruses pose a threat to humans deserves further
study. In the current assay, we chose a new genotype
avian influenza virus A/tree sparrow/Henan/1/04(H5N1)
isolated from a free-living tree sparrow in Henan
Figure 3 Involvement of RIG-I in recognizing influenza virus. (A) The A549 cells were cotransfected with the IFN-luc reporter gene, pCMV-
renilla, and RIG-I-flag K270A. At 16 h post transfection, the cells were infected with the H5N1 or H1N1 (m.o.i = 2). At 12 h post infection, the cells
were collected and luciferase reporter activity was measured with the Dual-Luciferase Reporter Assay System. In all cases, the data are shown as
mean± SD of triplicate samples of a representative from three independent experiments. (B) Overexpressing RIG-I increases STAT-1
phosphorylation induced by H1N1 or H5N1 infection. HEK293T cells were transfected with RIG-I flag. At 16 h posttransfection, cells were infected
with indicated influenza virus (m.o.i = 2). Then the cells were collected at 4 h and 8 h post infection, and western blot was used to detect STAT-1
phosphorylation, total STAT-1, RIG-I, and NS1 expression.
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of IFN-β and RIG-I in mammalian cells.
In contrast to human influenza virus H1N1, A/tree
sparrow/Henan/1/04(H5N1) infection in mammalian
cells resulted in rapid IFN-β production during the early
stage of infection, but in the late stage, it significantly
inhibited the amplification of IFN-β production and
showed the same pattern as the Indian isolate of pan-
demic (H1N1) 2009 influenza virus [32]. Previous stud-
ies have demonstrated that highly pathogenic avian
influenza virus H5N1 replicated more efficiently than
human influenza viruses due to its PA, PB1, and PB2
[33-35]. Our results also proved that A/tree sparrow/
Henan/1/04(H5N1) was consistent with other H5N1
strains and that it rapidly and efficiently amplified in
mammalian cells, which resulted in the rapid activation
of IFN-β signaling in early infection. However, accom-
panying rapid replication and viral cytoplasmic RNA ac-
cumulating, why the rapid IFN-β production was
followed with sharp downregulation during H5N1 infec-
tion is unknown. In this study, we observed that al-
though A/tree sparrow/Henan/1/04(H5N1) infection
caused rapid IFN-β production and STAT-1 phosphoryl-
ation during the early stage of infection, it only induced
low level endogenous RIG-I expression in comparison toH1N1 in A549 cells. Furthermore, when preinfecting the
293T cells, H5N1 significantly inhibited the endogenous
RIG-I expression induced by exogenous interferon than
H1N1. Previous investigation showed that low level
RIG-I existed in quiescent epithelial cells and ready to
sense invading RNA [16]. When the primary interferon
produced, it increased RIG-I expression, which again
participates in sensing invading RNA and amplifying
interferon production. So inhibiting RIG-I expression
unavoidly interrupt the above positive feed-back loop.
According to these results we assume that manipulating
RIG-I expression might be adopted by influenza virus at
least as one of strategies antagonizing host’s innate im-
mune response.
Although a latest literature found the polymerase of
H5N1 was involved in antagonzing interferon produc-
tion in chicken macrophage HD-11 cells [36], the NS1
has been regarded as the key component inhibiting
interferon production through targeting many aspects of
interferon signalling pathway [37]. In this study NS1
from H5N1 showed more potent inhibition to exogen-
ous interferon than NS1 from H1N1 in the same level of
expression. The same level of NS1 from different sub-
type or strain of influenza virus exhibiting diverse antag-
onizing capacity might attribute to its property [38,39].
Figure 4 H5N1 infection or NS1 overexpression showed potent inhibition to exogenous IFN. (A) HEK293T cells were pre-infected as
indicated. At 4 h post infection, the cells were treated with 2000 IU/ml of hIFNα2b (InvivoGen, San Diego, CA) for the indicated time. The
expression of endogenous RIG-I and NS1 were analyzed with western blot, beta-actin as loading control. (B) HEK293T cells were co-transfected
with the ISRE-luc reporter gene, pCMV-renilla, and NS1 constructs. At 16 h post transfection, cells were treated with 2000 IU/ml of hIFNa2b for 8
h. The cells were collected, and luciferase reporter activity was measured with the Dual-Luciferase Reporter Assay System. Fold induction is the
ratio of the activity induced by the hIFNa2b treatment to that of the untreated control. In all cases, data are shown as mean± SD of triplicate
samples. The expression level of NS1 constructs in HEK293T was shown in western blot and measured with Scion image software (National
Institute Health).
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infection might be responsible for the differences in in-
ducing interferon or RIG-I expression. Based on these
results, during the early stage of infection, H5N1 repli-
cates more efficiently than H1N1 and induced rapid
IFN-β production, but in the late stage of infection, itsignificantly inhibits IFN-β production with NS1 accu-
mulation as showed in influenza C virus NS1 [40].
Conclusion
Previous studies showed that multistep inhibition contri-
butes to the capacity of NS1 to antagonize the innate
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ition to PKR signaling by binding to double strand RNA
(dsRNA) [41,42], inhibition to nuclear export of polyade-
nylated host mRNA [43], and inhibition to mRNA
splicing and downregulation of IFN production by inter-
acting with CPSF (cleavage and polyadenylation specifi-
city factor) [44-46]. Here we showed that inhibiting
endogenous RIG-I expression is another mechanism
through which A/tree sparrow/Henan/1/04 (H5N1)
antagonizes IFN-β production. This further confirms
that the influenza virus inhibits the host innate immune
response through multiple steps and aspects.
Methods
Virus and cells
A/tree sparrow/Henan/1/04(H5N1) (kindly provided by
Professor Li TX, State Key Laboratory of Virology,
Wuhan Institute of Virology, Chinese Academy of
Sciences) and A/WSN/1933(H1N1) purchased from the
American Type Culture Collection (ATCC, Manassas,
VA) were propagated in 10-day-old embryonated
chicken eggs from specific-pathogen-free flocks (Beijing
Merial). Each egg was injected with 0.1 ml of phosphate-
buffered saline (PBS) containing ~103 infectious parti-
cles, incubated at 35°C with forced air circulation and
egg rotation, and maintained at 4°C for 12 h before har-
vesting. The allantoic fluid was harvested separately
from each egg. Those with high hemagglutinin activity
were pooled, and aliquots were prepared and stored at
−70°C. The hemagglutinin titer of the above subtype of
influenza virus was measured with 1% hamster blood
cell in a U-shaped plate. Human lung carcinoma cell
A549, human embryonic kidney 293T cell (HEK293T)
and Madin-Darby Canine Kidney Cell (MDCK) cell were
purchased from ATCC and maintained in minimal es-
sential medium (MEM, HyClone). All cell cultures were
supplemented with 10% fetal calf serum (PAA Labora-
tories, Germany), 100 U penicillin, and 100 μg strepto-
mycin per milliliter (Sigma-Aldrich, St. Louis). The cells
were incubated at 37°C and 5% carbon dioxide.
Tansfection
Transient transfection of A549 cells with the indicated
plasmids was conducted with Lipofectamin 2000 (Invitro-
gen) according to the manufacturer’s recommendation.
Transient transfection of HEK293T cells with indicated
plasmids was performed routinely with calcium phosphate
method. In each experiment total amounts of DNA in
each sample were kept constant by supplementation with
the appropriate empty parental expression vector.
Luciferase reporter assay
IFN-luc and ISRE-luc luciferase reporter plasmids were
described previously [47]. Briefly, the reporter plasmidswere co-transfected with the indicated constructs into
A549 cells or HEK293T cells. For normalization of trans-
fection efficiency, Renilla luciferase plasmid was co-
transfected as internal control of transfection efficiency.
Luciferase activities were measured and normalized as
per instructions by the manufacturer (Dual-Luciferase
reporter assay system, Promega, WI).
Plaque assay
Six-well tissue culture plates were seeded at 1 × 106
MDCK cells per well. At 100% confluence, the cells were
washed twice with PBS. Serial dilutions of the virus (10-2
to 10-7) were prepared in MEM containing 20 μg/ml
TPCK–trypsin (Sigma-Aldrich). After infection of the
wells with 0.5 ml of each dilution, the plates were incu-
bated at 37°C for 1.5 h. The wells were aspirated to re-
move residual viral solution. Each well was then
immediately covered with 2.5 ml MEM containing 0.8%
agar and 20 μg/ml TPCK–trypsin. About 5 min later, the
agar solidified. The plates were placed in the incubator.
After 24 hours, 1.5 ml of 1× neutral red was added per
well and incubated for 2 h. Then, the neutral red was
pipetted without touching the agar. The quantity of
plaque was counted, and the titer of virus was calculated
as plaque-forming unit (PFU) per milliliter.
Virus infection
For influenza virus infection, 2 × 106 A549 or 293T cells
were seeded in 60 mm-diameter dish. At 24 h post seeding,
cells were washed with PBS and infected with influenza
viruses (m.o.i = 2) in complete culture medium for 1 h,
then virus-containing solutions were removed and cells
were continuously cultured in complete culture medium in
5% CO2 incubator at 37°C. For mock infection, the same
amount of allantoic fluid from non-inoculated 10-day-old
chicken embryos was used to infect the A549 cells.
Quantitative real-time RT-PCR
The complementary DNA (cDNA) number of individual
avian influenza virus genes when oligo(dT) is used for
reverse transcription can be used to designate the viral
infection and amplification in host cells. For cDNA syn-
thesis, total RNA was extracted from the cells infected
with the indicated influenza virus using Trizol (Invitro-
gen, Carlsbad, CA), and reverse transcription was per-
formed with M-MLV reverse transcriptase and oligo(dT)
15 (Promega). Single-color real-time PCR System (Bio-
Rad, Hercules, CA) was used to detect the levels of in-
fluenza virus NP mRNA and IFN-β mRNA. The real-
time PCR primers were designed as the following: NP
gene, forward primer: 5′-GAC GAA AAG GCA ACG
AAC C-3′, reverse primer: 5′-TCA TAC TCC TCT
GCA TTG TCT C-3′; human IFN-β gene, forward pri-
mer: 5′-AAA CTC ATG AGC AGT CTG CA-3′,
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GAG G-3′; human β-actin gene, forward primer: 5′-
AGC GAG CAT CCC CCA AAG TT-3′; reverse primer:
5′-AGG GCA CGA AGG CTC ATC ATT-3′.
Western blot
The cells were lysed in ice-cold lysis buffer containing
50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% Nonidet
P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulfate (SDS), and a protease inhibitor cocktail (Sigma-
Aldrich). Protein concentrations were determined using
the Bradford reagent protocol (Bio-Rad). Equal amounts
of proteins were loaded on an SDS-polyacrylamide gel,
separated with electrophoresis, and blotted with the
indicated antibodies according to the manufacturer's
instructions. Immunoreactive proteins were detected
with monoclonal antibody against RIG-I (Alme-1; Alexis,
Plymouth Meeting, PA), rabbit anti-STAT1, phospho-
STAT-1 (Tyr701) (58D6; Cell Signaling Technologies,
Beverly, MA), anti-flag M2 monoclonal antibodies
(Sigma-Aldrich), anti-NS1 monoclonal antibodies (sc-
130568; Santa Cruz Biotechnology), anti-human β-actin
monoclonal antibodies (sc-130301; Santa Cruz Biotechnol-
ogy), and followed by horseradish peroxidase-conjugated
secondary antibodies (Cell Signaling Technologies).
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